China
· Delayed Price · Currency is CNY APT Medical Statistics
Total Valuation
APT Medical has a market cap or net worth of CNY 39.51 billion. The enterprise value is 38.61 billion.
| Market Cap | 39.51B |
| Enterprise Value | 38.61B |
Important Dates
The next estimated earnings date is Wednesday, April 23, 2025.
| Earnings Date | Apr 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
APT Medical has 96.94 million shares outstanding. The number of shares has decreased by -1.01% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 96.94M |
| Shares Change (YoY) | -1.01% |
| Shares Change (QoQ) | -1.79% |
| Owned by Insiders (%) | 22.11% |
| Owned by Institutions (%) | 39.01% |
| Float | 47.32M |
Valuation Ratios
The trailing PE ratio is 58.56 and the forward PE ratio is 42.87.
| PE Ratio | 58.56 |
| Forward PE | 42.87 |
| PS Ratio | 19.09 |
| PB Ratio | 16.53 |
| P/TBV Ratio | 20.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 57.33 |
| EV / Sales | 18.69 |
| EV / EBITDA | 47.71 |
| EV / EBIT | 51.21 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 30.63% and return on invested capital (ROIC) is 20.94%.
| Return on Equity (ROE) | 30.63% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 20.94% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 958,609 |
| Profits Per Employee | 312,518 |
| Employee Count | 2,155 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +38.09% in the last 52 weeks. The beta is -0.33, so APT Medical's price volatility has been lower than the market average.
| Beta (5Y) | -0.33 |
| 52-Week Price Change | +38.09% |
| 50-Day Moving Average | 369.64 |
| 200-Day Moving Average | 350.41 |
| Relative Strength Index (RSI) | 67.40 |
| Average Volume (20 Days) | 507,342 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, APT Medical had revenue of CNY 2.07 billion and earned 673.48 million in profits. Earnings per share was 6.96.
| Revenue | 2.07B |
| Gross Profit | 2.07B |
| Operating Income | 754.02M |
| Pretax Income | 746.29M |
| Net Income | 673.48M |
| EBITDA | 809.23M |
| EBIT | 754.02M |
| Earnings Per Share (EPS) | 6.96 |
Balance Sheet
The company has 960.58 million in cash and 12.44 million in debt, giving a net cash position of 948.14 million or 9.78 per share.
| Cash & Cash Equivalents | 960.58M |
| Total Debt | 12.44M |
| Net Cash | 948.14M |
| Net Cash Per Share | 9.78 |
| Equity (Book Value) | 2.44B |
| Book Value Per Share | 24.65 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of 36.50% and 32.60%.
| Gross Margin | 100.00% |
| Operating Margin | 36.50% |
| Pretax Margin | 36.13% |
| Profit Margin | 32.60% |
| EBITDA Margin | 39.17% |
| EBIT Margin | 36.50% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.38, which amounts to a dividend yield of 0.36%.
| Dividend Per Share | 1.38 |
| Dividend Yield | 0.36% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 4 |
| Payout Ratio | n/a |
| Buyback Yield | 1.01% |
| Shareholder Yield | 1.37% |
| Earnings Yield | 1.70% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on July 26, 2024. It was a forward split with a ratio of 1.45.
| Last Split Date | Jul 26, 2024 |
| Split Type | Forward |
| Split Ratio | 1.45 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |